Richard Oneill, MD
Geriatric Medicine · Saint Louis, MONPI 1265570485
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novo Nordisk at 24.5% of the total. Reporting peaked in 2020 at $379 and has fallen 72.1% since, to $106 in 2023.
Across 80 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$346
- Lilly USA, LLC$239
- Amarin Pharma, Inc.$206
- AbbVie$118
- Johnson & Johnson$69
- Pfizer$65
- plus $367 from 15 others
What the payments were for
- Food & beverage$1,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $346 |
| Lilly USA, LLC | 12 | $239 |
| Amarin Pharma, Inc. | 12 | $206 |
| AbbVie(2 entities) | 8 | $118 |
| Johnson & Johnson | 3 | $69 |
| Pfizer | 4 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Novartis | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| GSK | 2 | $31 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Merck | 1 | $23 |
| Medtronic | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Boston Scientific | 1 | $11 |
How this compares
$1,411 in reported general payments places this provider in the 75th percentile of 76 geriatric medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 65 | $72,378 |
| OzempicSemaglutide | 40 | $56,515 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $34,559 |
| JardianceEmpagliflozin | 30 | $32,786 |
| JanuviaSitagliptin Phosphate | 16 | $24,102 |
| XareltoRivaroxaban | 19 | $16,832 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 303 | $8,817 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $8,445 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 136 | $5,937 |
| Memantine Hcl ErMemantine Hcl | 25 | $4,939 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $4,666 |
| Levothyroxine Sodium | 387 | $4,572 |
| Atorvastatin Calcium | 397 | $4,288 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 122 | $3,560 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,547 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $72,37865 claims |
| Novo NordiskOzempic | $346 | $56,51540 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $31 | $43,00464 claims |
| Boehringer IngelheimJardiance | $14 | $32,78630 claims |
| MerckJanuvia | $23 | $24,10216 claims |
| Johnson & JohnsonXarelto | $69 | $16,83219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 76 geriatric medicine providers in Missouri.
Other geriatric medicine in Saint Louis
- Angela SanfordSaint Louis$15K
- Ellen BinderSaint Louis$4K
- Poonam JainSaint Louis$4K
- Uchenna OgbuokiriSaint Louis$3K
- Charles CreceliusSaint Louis$3K
- Seema IyerSaint Louis$2K
- Hanish Sampath KumarSaint Louis$2K
- Mark GunbySaint Louis$1K
- David CarrSaint Louis$1K
- Susan ReedsSaint Louis$725
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.